The ketogenic diet modifies social and metabolic alterations identified in the prenatal valproic acid model of autism spectrum disorder

Developmental Neuroscience

Volumn 36, Issue 5, 2014, Pages 371-380

  Ahn, Younghee ^a   Narous, Mariam ^a   Tobias, Rose ^a   Rho, Jong M ^a   Mychasiuk, Richelle ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Autism; Metabolism; Mitochondria; Play behavior; Respiration; Valproic acid

Indexed keywords

SODIUM CHLORIDE; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTISM; BIOENERGY; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FIGHTING; GESTATIONAL AGE; KETOGENIC DIET; MALE; METABOLIC CAPACITY; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRENATAL EXPOSURE; PRENATAL PERIOD; PRIORITY JOURNAL; PROGENY; RAT; SOCIAL ASPECT; SOCIAL BEHAVIOR; ANIMAL; ANIMAL BEHAVIOR; CHEMICALLY INDUCED; DIET THERAPY; DISEASE MODEL; METABOLISM; MITOCHONDRION; PHYSIOLOGY; PREGNANCY; RECREATION; SPRAGUE DAWLEY RAT;

ANIMALS; BEHAVIOR, ANIMAL; CHILD DEVELOPMENT DISORDERS, PERVASIVE; DISEASE MODELS, ANIMAL; FEMALE; KETOGENIC DIET; MALE; MITOCHONDRIA; PLAY AND PLAYTHINGS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; SOCIAL BEHAVIOR; VALPROIC ACID;

EID: 84927698413     PISSN: 03785866     EISSN: 14219859     Source Type: Journal    
DOI: 10.1159/000362645     Document Type: Article

References (50)

1. Mefford HC, Batshaw ML, Hoffman, EP. Genomics, intellectual disability, and autism. N Engl J Med. 2012; 366: 733-743
2. Haas R. Autism and mitochondrial disease. Dev Disabil Res Rev. 2010; 16: 144-153
3. Veenstra-Vander Weele J, Blakely RD. Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments. Neuropsychopharmacology. 2012; 37: 196-212
4. Persico AM, Bourgeron T. Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci. 2006; 29: 349-358
5. Rinaldi T, Kulangara K, Antoniello K, Markram H. Elevated NMDA receptor levels and enhanced postsynaptic long-Term potentiation induced by prenatal exposure to valproic acid. Proc Natl Acad Sci USA. 2007; 104: 13501-13506
6. Williams G, King J, Cunningham M, Stephan M, Kerr B, Hersh JH. Fetal valproate syndrome and autism: additional evidence of an association. Dev Med Child Neurol. 2001; 43: 202-206
7. Rasalam AD, Hailey H, Williams JH, Moore SJ, Turnpenny PD, Lloyd DJ, Dean JC. Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Dev Med Child Neurol. 2005; 47: 551-555
8. Christensen J, Koops Gronborg T, Juul Sorensen M, Schendel D, Thorlund Parner E, Henning Pedersen L, Vestergaard M. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA. 2013; 309: 1696-1703
9. Arndt TL, Stodgell CJ, Rodier PM. The teratology of autism. Int J Dev Neurosci. 2005; 23: 189-199
10. Schneider T, Przewlocki R. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology. 2005; 30: 80-89
11. Ingram J, Peckham S, Tisdale B, Rodier P. Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol Teratol. 2000; 22: 319-324
12. Rodier P. Animal model of autism based on developmental data. Ment Retard Dev Disabil Res Rev. 1996; 2: 249-256
13. Mychasiuk R, Richards S, Nakahashi A, Kolb B, Gibb R. Effects of prenatal exposure to valproic acid on behaviour and neuro-Anatomy. Dev Neurosci. 2012; 34: 268-276
14. Chomiak T, Turner N, Hu B. What we have learned about autism spectrum disorder from valproic acid. Patholog Res Int. 2013; 2013: 71275 8
15. Rossignol D, Frye R. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-Analysis. Mol Psychiatry. 2012; 17: 290-314
16. Masino S, Rho J. Mechanisms of ketogenic diet action; in J. Noebels, M. Avoli, M. Rogawski (eds): Jasper's Basic Mechanisms of the Epilepsies. Bethesda, National Center for Biotechnology Information, 2012
17. Bough KJ, Wetherington J, Hassel B, Pare JF, Gawryluk JW, Greene J, Shaw R, Smith Y, Geiger J, Dingledine RJ. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann Neurol. 2006; 60: 223-235
18. Wilder RM. The effects of ketonemia on the course of epilepsy. Mayo Clin Proc. 1921; 2: 2
19. McDaniel SS, Rensing NR, Thio LL, Yamada KA, Wong M. The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway. Epilepsia. 2011; 52: e7-e11
20. Wheless JW. The ketogenic diet: fa(c)t or fiction. J Child Neurol. 1995; 10: 419-423
21. Nordli DR Jr, De Vivo DC. The ketogenic diet revisited: back to the future. Epilepsia. 1997; 38: 743-749
22. Vining EP, Freeman JM, Ballaban-Gil K, Camfield CS, Camfield PR, Holmes GL, Shinnar S, Shuman R, Trevathan E, Wheless JW A multicenter study of the efficacy of the ketogenic diet. Arch Neurol. 1998; 55: 1433-1437
23. Kim do Y, Davis LM, Sullivan PG, Maalouf M, Simeone TA, van Brederode J, Rho J. Ketone bodies are protective against oxidative stress in neocortical neurons. J Neurochem. 2007; 101: 1316-1326
24. Kim do Y, Hao J, Liu R, Turner G, Shi FD, Rho J. Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis. PLoS One. 2012; 7: e35476
25. Haas RH, Rice MA, Trauner DA, Merritt TA. Therapeutic effects of a ketogenic diet in Rett syndrome. Am J Med Genet Suppl. 1986; 1: 225-246
26. Liebhaber GM, Riemann E, Baumeister FA. Ketogenic diet in Rett syndrome. J Child Neurol. 2003; 18: 74-75
27. Bujas-Petkovic Z, Matijasic R, Divcic B. Rett's syndrome - differential diagnosis of autism in a case report. Lijec Vjesn. 1989; 111: 458-460
28. Chahrour M, Zoghbi HY. The story of Rett syndrome: from clinic to neurobiology. Neuron. 2007; 56: 422-437
29. Francke U. Mechanisms of disease: neurogenetics of MeCP2 deficiency. Nat Clin Pract Neurol. 2006; 2: 212-221
30. LaSalle JM, Yasui DH. Evolving role of MeCP2 in Rett syndrome and autism. Epigenomics. 2009; 1: 119-130
31. Evangeliou A, Vlachonikolis I, Mihailidou H, Spilioti M, Skarpalezou A, Makaronas N, Prokopiou A, Christodoulou P, Liapi-Adamidou G, Helidonis E, Sbyrakis S, Smeitink J. Application of a ketogenic diet in children with autistic behavior: pilot study. J Child Neurol. 2003; 18: 113-118
32. Williams E, Reddy V, Costall A. Taking a closer look at functional play in children with autism. J Autism Dev Disord. 2001; 31: 67-77
33. Bell H, Pellis S, Kolb B. Juvenile peer play experience and the development of the orbitofrontal and medial prefrontal cortices. Behav Brain Res. 2010; 207: 7-13
34. Pellis S, Pellis V. Rough and tumble play and the development of the social brain. Curr Dir Psychol Sci. 2007; 16: 95-98
35. Kataoka S, Takuma K, Hara Y, Maeda Y, Ago Y, Matsuda T. Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid. Int J Neuropsychopharmacol. 2013; 16: 91-103
36. Chomiak T, Karnik V, Block E, Hu B. Altering the trajectory of early postnatal cortical development can lead to structural and behavioural features of autism. BMC Neurosci. 2010; 11: 102
37. Fenoglio-Simeone KA, Wilke JC, Milligan HL, Allen CN, Rho, JM, Maganti RK. Ketogenic diet treatment abolishes seizure periodicity and improves diurnal rhythmicity in epileptic Kcna1-null mice. Epilepsia. 2009; 50: 2027-2034
38. Pellis SM, Pellis VC. Play fighting of rats in comparative perspective: a schema for neurobehavioral analyses. Neurosci Biobehav Rev. 1998; 23: 87-101
39. Pellis S, Pellis V. Differential rates of attack, defense and counterattack during development decrease in play fighting by male and female rats. Dev Psychobiol. 1990; 23: 215-231
40. Sullivan P, Dube C, Dorenbos K, Oswald S, Baram T. Mitochondrial uncoupling protein-2 protects the immature brain from excitotoxic neuronal death. Ann Neurol. 2003; 53: 711-717
41. Sullivan P, Rippy N, Dorenbos K, Concepcion R, Agarwal A, Rho J. The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann Neurol. 2004; 55: 576-580
42. Pandya J, Pauly J, Sullivan P. The optimal dosage and window of opportunity to maintain mitochondrial homeostasis following traumatic brain injury using the uncoupler FCCP. Exp Neurol. 2009; 218: 381-389
43. Courchesne E, Pierce K, Schumann CM, Redcay E, Buckwalter JA, Kennedy DP, Morgan J. Mapping early brain development in autism. Neuron. 2007; 56: 399-413
44. Schumann CM, Bloss CS, Barnes CC, Wideman GM, Carper RA, Akshoomoff N, Pierce K, Hagler D, Schork N, Lord C, Courchesne E. Longitudinal magnetic resonance imaging study of cortical development through early childhood in autism. J Neurosci. 2010; 30: 4419-4427
45. Pellis S, Pellis V, Bell H. The function of play in the development of the social brain. Am J Play. 2010; 2: 278-296
46. Hol T, Van den Berg M, Van Ree J, Spruijt B. Isolation during the play period in infancy decreases adult social interactions in rats. Behav Brain Res. 1999; 100: 91-97
47. Parihar M, Brewer G. Mitoenergetic failure in Alzheimer disease. Am J Physiol. 2007; 292: C8-C23
48. Brand M, Nichols D. Assessing mitochondrial dysfunction in cells. Biochem J. 2001; 435: 297-312
49. Stafstrom CE, Rho JM. The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front Pharmacol. 2012; 3: 59
50. Morris A. Cerebral ketone body metabolism. J Inherit Metab Dis. 2005; 28: 109-121